Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting No phase listed Observational

Impact of Vitamin D on Gut Microbiome and Metabolome Among Pediatric Oncology Patients

ClinicalTrials.gov ID: NCT07938333

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07938333. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 16, 2026, 8:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Brief Summary The purpose of this observational study is to better understand how vitamin D levels affect the gut microbiome (the bacteria that live in the intestines) in children who are newly diagnosed with acute lymphoblastic leukemia (ALL). Researchers want to learn whether low vitamin D levels are linked to changes in gut bacteria and whether this may affect how children with ALL respond to chemotherapy. The main questions this study aims to answer are: * Are the gut bacteria different in children with ALL who have low vitamin D levels compared to those with normal vitamin D levels at the time of diagnosis? * How do vitamin D levels relate to changes in gut bacteria and related body processes before and after induction chemotherapy? Researchers will compare children who have low vitamin D levels with those who have normal vitamin D levels to see if there are differences in their gut bacteria and how those bacteria change during early treatment. The stool samples will be studied in specialized laboratories to better understand how vitamin D and gut bacteria interact. The results of this study may help doctors understand whether monitoring and managing vitamin D levels could improve care and treatment outcomes for children with ALL. Participants will: Have four study visits: * Screening: Review and sign consent/assent forms, review of Inclusion/Exclusion Criteria, medical history, and current medications * At diagnosis (baseline): Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection * Day 29-32 - At the end of induction chemotherapy: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment * Day 90-97 after Induction: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment

Study identification

NCT ID
NCT07938333
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Enrollment
30 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
0 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 9, 2026 (Estimated)
Primary completion
Aug 31, 2027 (Estimated)
Completion
Dec 31, 2027 (Estimated)
Last update posted
Nov 16, 2026

2026 – 2027

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Children's Hospital of Orange County Orange California 92868 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07938333, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2026 · Synced Nov 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.